The synthesis of a series of novel docetaxel analogues possessing a peptide side chain at the C2 position as well as peptide macrocyclic taxoids is described. These compounds were designed to mimic a region of the alpha-tubulin loop equivalent to the paclitaxel binding pocket of beta-tubulin. Fifteen new peptide taxoids were obtained and evaluated as inhibitors of microtubule disassembly as well as cell proliferation. The relationships between these new taxoids and the tau protein motif interacting with microtubules are discussed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bmc.2006.09.030 | DOI Listing |
Value Health
January 2023
BresMed Health Solutions, Sheffield, England, UK.
Objectives: This study aimed to compare the relative efficacy of lorlatinib, an anaplastic lymphoma kinase-tyrosine kinase inhibitor, with chemotherapy, for patients with second-line or later advanced anaplastic lymphoma kinase-positive non-small cell lung cancer. The endpoints of interest were overall survival (OS) and progression-free survival (PFS).
Methods: Evidence for lorlatinib was informed by the single-arm phase I/II trial B7461001.
Clin Transl Oncol
November 2022
Department of Oncology, General Hospital of Southern Theater Command, PLA, No.111, Liuhua Rd., Guangzhou, 510010, China.
Purpose: Although lorlatinib, the third generation of echinoderm microtubule protein 4-anaplastic lymphoma kinase (EML4-ALK) tyrosine kinase inhibitor (TKI), overcame the previous generation ALK-TKIs' drug resistance problems, but the mechanism of lorlatinib resistance remained unclear. Furthermore, optimal chemotherapy for lorlatinib-resistant non-small cell lung cancer (NSCLC) patients was still unknown.
Methods: A lorlatinib-resistant NSCLC cell line SNU-2535LR was generated by gradually increasing dose of lorlatinib to crizotinib-resistant cell line SNU-2535 in vitro.
J Nat Prod
April 2022
Faculty of Pharmaceutical Sciences, Toho University, Miyama 2-2-1, Funabashi, Chiba 274-8510, Japan.
A phytochemical investigation on the aerial parts of resulted in the isolation of 27 macrocyclic diterpenoids, including three previously unreported lathyrane derivatives, euphohelioscopoids A-C (-). Their structures were elucidated by spectroscopic data interpretation. Three jatrophanes, euphoscopin C (), euphorbiapene D (), and euphoheliosnoid A (), showed cytotoxicity against a paclitaxel-resistant A549 human lung cancer cell line with IC values of 6.
View Article and Find Full Text PDFPlant Physiol Biochem
June 2021
Secció de Fisiologia Vegetal, Facultat de Farmacia, Universitat de Barcelona, Barcelona, Spain. Electronic address:
Paclitaxel (PTX), a widely used anticancer agent, is found in the inner bark of several Taxus species, although at such low levels that its extraction is ecologically unsustainable. Biotechnological platforms based on Taxus sp. cell cultures offer an eco-friendlier approach to PTX production, with yields that can be improved by elicitation.
View Article and Find Full Text PDFLung Cancer
December 2020
Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital, Changsha, 410013, China; The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, 410013, China. Electronic address:
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!